Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_assertion type Assertion NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_head.
- NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_assertion description "[Further, studies on knockout/transgenic mice showed that the metabolic consequences of Dp(11)17 and Df(11)17 CNVs are not only due to dosage alterations of Rai1, the predominant dosage-sensitive gene for SMS and likely also PTLS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_provenance.
- NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_assertion evidence source_evidence_literature NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_provenance.
- NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_assertion SIO_000772 22654670 NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_provenance.
- NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_assertion wasDerivedFrom befree-20150227 NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_provenance.
- NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_assertion wasGeneratedBy ECO_0000203 NP852320.RA6nAG9tPjwhT8MIVV4NqIfzd8F7HqHy9jx1SSt28YWCo130_provenance.